학술논문
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
Document Type
Article
Author
Pfister, C.; Harter, V.; Allory, Y.; Radvanyi, F.; Culine, S.; Grawis, G.; Pignot, G.; Flechon, A.; Fendler, J.P.; Chevreau, C.; Soulie, M.; Mahammedi, H.; Guy, L.; Laguerre, B.; Verhoest, G.; Guillot, A.; Mottet, N.; Joly, F.; Doerfler, A.; Abadie-Lacourtoisie, S.; Azzouzi, A.R.; Mongiat, P.; Geoffrois, L.; Eschwege, P.; Di Fiore, F.; Roubaud, G.; Hoepffner, J.L.; Barthelemy, P.; Lang, H.; Voog, E.; Mandron, E.; Tourani, J.M.; Serrrate, C.; Colau, A.; Saldana, C.; de La Taille, A.; Nguyen, T.; Kleinclauss, F.; Loriot, Y.; Irani, J.; Eymard, J.C.; Larre, S.; Huillard, O.; Zerbib, M.; Rolland, F.; Rigaud, J.; Houede, N.; Droupy, S.; Malouf, G.; Roupret, M.; El Demery, M.; Legon, C.; Vieillot, S.; Letang, N.; Lharidon, T.; Gaschignard, N.; Hilgers, W.; Davin, J.L.
Source
In: Contemporary Clinical Trials Communications . (Contemporary Clinical Trials Communications, March 2020, 17)
Subject
Language
English
ISSN
24518654